new weight loss drug glp-1 The U.S. Food and Administration approved Eli Lilly's pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for weight-loss medications Patent and Innovation Trends in
Description
This primer in our Toolkit was one of our most popular pieces
PMCID: PMC7922953
Once-monthly maridebart cafraglutide for the treatment of obesity - A phase 2 trial
Understanding Satiety vs
14 by the health policy nonprofit KFF
Most pregnancies result in healthy babies, but there are chances of complications and unexpected outcomes
